Luigi Mele, Vitale Del Vecchio, Francesco Marampon, Tarik Regad, Sarah Wagner, Laura Mosca, Sabrina Bimonte, Aldo Giudice, Davide Liccardo, Claudia Prisco, Melanie Schwerdtfeger, Marcella La Noce, Virginia Tirino, Michele Caraglia, Gianpaolo Papaccio, Vincenzo Desiderio, Antonio Barbieri
The β2-Adrenergic receptor (β2-AR) is a G protein-coupled receptor (GPCR), involved in the development of many cancers, among which HNSCC. In this contest, β2-AR signaling interacts with different pathways, such as PI3K and MAPK, commonly activated by TK receptors. For this reason, TK blockade is one of the most adopted therapeutic strategies in HNSCC patients. In our study we investigated the effects of the β2-AR blocking in HNSCC cell lines, using the selective inhibitor ICI118,551 (ICI), in combination with the MAPK inhibitor U0126...
October 13, 2020: Cell Death & Disease